Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator
- 1 April 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 19 (5), 1065-1069
- https://doi.org/10.1016/0735-1097(92)90296-y
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.JCI Insight, 1990
- Coronary thrombolysisCoronary Artery Disease, 1990
- Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole bloodThrombosis Research, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA)Thrombosis Research, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- Fibrinopeptide A: a marker of acute coronary thrombosis.Circulation, 1985